Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis

Sarah E. Graham, Jonas B. Nielsen, Matthew Zawistowski, Wei Zhou, Lars G. Fritsche, Maiken E. Gabrielsen, Anne Heidi Skogholt, Ida Surakka, Whitney Hornsby, Damian Fermin, Daniel B. Larach, Sachin Kheterpal, Chad M. Brummett, Seunggeun Lee, Hyun Min Kang, Gonçalo R. Abecasis, Solfrid Romundstad, Stein Hallan, Matthew G. Sampson, Kristian Hveem, Cristen J. Willer

TL;DR

This study performed a large-scale genome-wide association study (GWAS) meta-analysis to identify genetic variants associated with kidney function (eGFR). They discovered 147 genetic loci, including 53 novel ones, and found one locus with a sex-specific effect, suggesting different genetic underpinnings of kidney function in men and women. While these genetic risk scores can predict CKD, they offer only modest improvements over existing clinical risk factors, highlighting the complex interplay of genetics and environment in kidney disease.

What Problem Does This Paper Address?

Chronic kidney disease (CKD) is a significant global health issue, affecting a substantial portion of the adult population. Estimated glomerular filtration rate (eGFR) is a key indicator of kidney function used for diagnosing and monitoring CKD. While genetics is known to play a role in kidney function, previous GWAS meta-analyses had limited sample sizes, potentially missing important genetic associations. This paper aims to expand our understanding of the genetic architecture of kidney function by conducting a larger GWAS meta-analysis, identifying novel genetic loci, and investigating sex-specific genetic influences and the pleiotropic effects of kidney function genes on related traits.

Methods

The researchers employed a multi-pronged approach:

  • GWAS Meta-Analysis: They combined data from multiple large cohorts (HUNT, MGI, CKDGen, BioBank Japan) to perform a meta-analysis of eGFR associations. This significantly increased the sample size compared to previous studies.
  • Imputation: They used advanced imputation panels (HRC and ancestry-specific panels) to increase the density of genetic variants analyzed.
  • Gene Prioritization: To interpret the identified genetic loci, they used several methods:
  • Missense variants: Identifying variants that directly alter protein sequences.
  • DEPICT: A tool that prioritizes genes based on their expression patterns in different tissues and their involvement in biological pathways.
  • eQTL analysis: Identifying variants that influence gene expression, specifically in kidney tissues.
  • Mendelian kidney disease genes: Looking for overlap with genes known to cause severe kidney disorders.
  • Sex-Stratified Analysis: They specifically analyzed eGFR associations separately in men and women to identify any sex-specific genetic effects.
  • Pleiotropy Analysis (PheWAS): They investigated whether the identified eGFR variants were also associated with other related health conditions, such as diabetes and cardiovascular diseases, using phenome-wide association studies (PheWAS) in the UK Biobank.
  • Genetic Risk Scores (GRS): They constructed GRS using the identified eGFR variants to assess their predictive power for CKD and their contribution to eGFR heritability.

Datasets

The study utilized data from the following cohorts:

  • Nord-Trøndelag Health Study (HUNT): A longitudinal, population-based health survey in Norway.
  • Michigan Genomics Initiative (MGI): A biobank linking electronic medical records and genetic data from the University of Michigan.
  • CKDGen Consortium: A collection of meta-analysis results from 33 individual studies of European ancestry.
  • BioBank Japan (BBJ): A registry of patients with common diseases in Japan.
  • UK Biobank: Used for validation of genetic associations with related traits and for constructing and testing genetic risk scores for CKD.

The study did not introduce new benchmark datasets but rather leveraged existing large-scale biobanks and consortium data.

Key Insights and Ideas

  • Uncovering Novel Genetic Loci: By significantly increasing the sample size, the study identified 53 novel genetic loci associated with eGFR, expanding the known genetic landscape of kidney function. This suggests that previous studies may have been underpowered to detect these associations.
  • Sex-Specific Genetic Influence: The identification of a locus with a stronger effect in women than in men is a crucial finding. It highlights that the genetic regulation of kidney function is not uniform across sexes and warrants further investigation into the underlying biological mechanisms.
  • Pleiotropic Nature of Kidney Genes: The association of eGFR variants with other traits like hypertension, diabetes, and lipid metabolism disorders underscores the pleiotropic nature of genes involved in kidney function. This suggests shared biological pathways and potential common mechanisms underlying these interconnected conditions.
  • Limited Predictive Power of GRS for CKD: While genetic risk scores built from eGFR variants can predict CKD, their improvement over established clinical risk factors (like age, sex, diabetes, hypertension) was modest. This implies that while genetics plays a role, environmental and lifestyle factors remain critical in CKD development and progression.
  • Cell-Type Specific Gene Expression: The study's integration of eQTL data with kidney cell-type specific expression patterns provides a valuable link between genetic variants and specific kidney cell functions, offering a pathway for future mechanistic studies.

Key Results

  • 147 loci associated with eGFR: Of these, 53 were novel.
  • 7.6% of eGFR heritability explained: By the identified loci.
  • One locus with sex-specific association: Found to be more significant in women.
  • Significant overlap with related traits: 7 loci colocalized with hypertension/cardiovascular traits, and one with type 2 diabetes.
  • GRS explained 25.3% of eGFR variance: When using all independent markers.
  • GRS improved CKD prediction modestly: Adding a GRS to clinical risk factors increased the AUC for CKD prediction from 0.865 to 0.868.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of Direct Replication: Due to the large sample size required for meta-analysis, direct replication of all eGFR associations in a separate, equally large cohort was not feasible.
  • Cohort Heterogeneity: The study combined cohorts with different selection criteria (population-based vs. disease-selected) and variations in eGFR calculation methods, which could introduce some noise.
  • Modest GRS Predictive Power: The GRS, while informative, did not dramatically improve CKD prediction beyond existing clinical factors, suggesting that other genetic or environmental factors are at play.

Future work suggested by the authors includes:

  • Experimental Validation: Conducting experimental studies to validate the role of identified genes in kidney function.
  • Diverse Cohort Studies: Performing genetic studies in more diverse populations to ensure generalizability.
  • Mechanistic Studies: Investigating the specific biological pathways and cell types affected by the identified genetic variants, particularly the sex-specific locus.
  • Integration with Other Omics Data: Combining GWAS data with other types of molecular data (e.g., transcriptomics, epigenomics) to gain a more comprehensive understanding of kidney disease pathogenesis.

Summary updated

Abstract

Chronic kidney disease (CKD) is a growing health burden currently affecting 10-15% of adults worldwide. Estimated glomerular filtration rate (eGFR) as a marker of kidney function is commonly used to diagnose CKD. We analyze eGFR data from the Nord-Trøndelag Health Study and Michigan Genomics Initiative and perform a GWAS meta-analysis with public summary statistics, more than doubling the sample size of previous meta-analyses. We identify 147 loci (53 novel) associated with eGFR, including genes involved in transcriptional regulation, kidney development, cellular signaling, metabolism, and solute transport. Additionally, sex-stratified analysis identifies one locus with more significant effects in women than men. Using genetic risk scores constructed from these eGFR meta-analysis results, we show that associated variants are generally predictive of CKD with only modest improvements in detection compared with other known clinical risk factors. Collectively, these results yield additional insight into the genetic factors underlying kidney function and progression to CKD.
BibTeX
@inproceedings{graham2019sex,
  author = {Sarah E. Graham and Jonas B. Nielsen and Matthew Zawistowski and Wei Zhou and Lars G. Fritsche and Maiken E. Gabrielsen and Anne Heidi Skogholt and Ida Surakka and Whitney Hornsby and Damian Fermin and Daniel B. Larach and Sachin Kheterpal and Chad M. Brummett and Seunggeun Lee and Hyun Min Kang and Gonçalo R. Abecasis and Solfrid Romundstad and Stein Hallan and Matthew G. Sampson and Kristian Hveem and Cristen J. Willer},
  title = {{Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis}},
  booktitle = {Nature Communications},
  year = {2019},
  doi = {10.1038/s41467-019-09861-z},
}
Figure